SEOUL, July 12 (Reuters) – South Korea's top financial regulator said on Thursday that drug manufacturer Samsung BioLogics Co Ltd had violated
See Original Article

U.S. consumer prices rose less than expected in June amid falling utility prices and a record decline in hotel costs, even as the broader trend showed
See Original Article

South Korea's top financial watchdog has ruled that Samsung BioLogics, the biopharmaceutical unit of Samsung Group, violated accounting rules in
See Original Article

His departure from the traditional world of finance follows that of CBA's finance chief Rob Jesudason, who left the bank in May to run Hong-Kong
See Original Article

Law360 (July 12, 2018, 7:10 PM EDT) — The Seventh Circuit on Thursday affirmed the dismissal of a proposed class action against Kohl's Corp. over
See Original Article